FOXP1

FOXP1 Gene

<div class=“infobox” style=“float:right;clear:right;background:#0d1a2e;border:1px solid rgba(79,195,247,0.25);border-radius:8px;padding:1rem 1.2rem;margin:0 0 1.2rem 1.5rem;max-width:260px;font-size:0.85rem;line-height:1.6”>

FOXP1 Gene

</div>

FOXP1 (Forkhead Box P1) is a transcription factor encoded by the FOXP1 gene located on chromosome 3p13. This gene plays critical roles in neuronal development, motor circuit formation, B-cell differentiation, and the development of speech and language circuits. Mutations in FOXP1 cause FOXP1 syndrome, a neurodevelopmental disorder characterized by intellectual disability, childhood apraxia of speech, and autistic features. The gene’s involvement in corticobasal ganglia circuits makes it particularly relevant to understanding both developmental speech disorders and neurodegenerative conditions such as Huntington’s disease[@genereviews2023][@hamdan2010]. PMID:38594460

Overview

flowchart TD
    FOXP1["FOXP1"] -->|"upregulates"| FBXL7["FBXL7"]
    FOXP1["FOXP1"] -->|"regulates"| FBXL7["FBXL7"]
    FOXP1["FOXP1"] -->|"regulates"| Cancer["Cancer"]
    FOXP1["FOXP1"] -->|"activates"| Aging["Aging"]
    FOXP1["FOXP1"] -->|"associated with"| Autism["Autism"]
    FOXP1["FOXP1"] -->|"regulates"| Neurodegeneration["Neurodegeneration"]
    FOXP1["FOXP1"] -->|"regulates"| Multiple_Sclerosis["Multiple Sclerosis"]
    FOXP1["FOXP1"] -->|"regulates"| Inflammation["Inflammation"]
    FOXP1["FOXP1"] -->|"regulates"| Als["Als"]
    AURKA["AURKA"] -->|"interacts with"| FOXP1["FOXP1"]
    AURKA["AURKA"] -.->|"inhibits"| FOXP1["FOXP1"]
    AURKA["AURKA"] -->|"regulates"| FOXP1["FOXP1"]
    HSPA4["HSPA4"] -->|"regulates"| FOXP1["FOXP1"]
    CD38["CD38"] -->|"therapeutic target"| FOXP1["FOXP1"]
    FOXA2["FOXA2"] -->|"associated with"| FOXP1["FOXP1"]
    FOXO6["FOXO6"] -->|"associated with"| FOXP1["FOXP1"]
    FOXO3["FOXO3"] -->|"associated with"| FOXP1["FOXP1"]
    FOXP3["FOXP3"] -->|"associated with"| FOXP1["FOXP1"]
    style FOXP1 fill:#ce93d8,stroke:#333,color:#000
    style FBXL7 fill:#ce93d8,stroke:#333,color:#000
    style Cancer fill:#ef5350,stroke:#333,color:#000
    style Aging fill:#ef5350,stroke:#333,color:#000
    style Autism fill:#ef5350,stroke:#333,color:#000
    style Neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#000
    style Inflammation fill:#ef5350,stroke:#333,color:#000
    style Als fill:#ef5350,stroke:#333,color:#000
    style AURKA fill:#ce93d8,stroke:#333,color:#000
    style HSPA4 fill:#ce93d8,stroke:#333,color:#000
    style CD38 fill:#ce93d8,stroke:#333,color:#000
    style FOXA2 fill:#ce93d8,stroke:#333,color:#000
    style FOXO6 fill:#ce93d8,stroke:#333,color:#000
    style FOXO3 fill:#ce93d8,stroke:#333,color:#000
    style FOXP3 fill:#ce93d8,stroke:#333,color:#000

FOXP1 (Forkhead Box P1) encodes a transcription factor critical for neuronal development, motor circuit formation, B-cell differentiation, and – most notably – the development of speech and language circuits. While its paralog FOXP2 is widely known as the “language gene,” FOXP1 is equally, if not more, important for human speech: haploinsufficiency causes FOXP1 syndrome, a neurodevelopmental disorder whose hallmark is childhood apraxia of speech and severe expressive language delay[“@genereviews2023”]. Unlike FOXP2 mutations, which typically spare intellectual function, FOXP1 mutations produce a broader phenotype including moderate intellectual disability[“@hamdan2010”][@lozano2021]PMID:41716553.

FOXP1 Syndrome

FOXP1 syndrome (OMIM #613670) arises from heterozygous loss-of-function mutations or chromosomal deletions at 3p13, making it one of the more common single-gene causes of neurodevelopmental disorder with absent or severely delayed speech[@oroak2011][@genereviews2023]. The core features of this condition include intellectual disability ranging from mild to moderate (with IQ typically between 40-70), speech and language impairment with expressive language more severely affected than receptive – childhood apraxia of speech being the most disabling feature – autistic features such as social communication difficulties, restricted interests, and repetitive behaviours diagnosed in approximately 39% of cases, and behavioural abnormalities including anxiety, ADHD-like symptoms, and emotional dysregulation[@hamdan2010][@meerschaut2017][@lozano2021][@deriziotis2017][@stewart2025]. PMID:40349340

FOXP1 mutations account for approximately 0.5-1% of autism cases with intellectual disability[@oroak2011]. The speech phenotype is distinct from FOXP2-associated developmental verbal dyspraxia: FOXP1 patients show a broader neurodevelopmental syndrome with moderate intellectual disability, whereas FOXP2 patients typically have isolated apraxia with near-normal IQ[@lozano2021]. PMID:41716553

Speech and Language Disorder

FOXP1 haploinsufficiency causes a syndrome of expressive language delay and childhood apraxia of speech (CAS) that is mechanistically related to, but clinically broader than, FOXP2-associated dyspraxia[@deriziotis2017]. Unlike FOXP2 mutations – which primarily affect apraxia of speech with relatively preserved intellectual function – FOXP1 mutations produce moderate intellectual disability alongside the speech deficit[@genereviews2023].

The speech deficit in FOXP1 syndrome often manifests as near-absent or severely reduced expressive language in the first years of life, progressing to telegraphic speech or simple sentences with intervention. Receptive language is typically better preserved, creating a marked expressive-receptive discrepancy[@hamdan2010]. Critically, FOXP1 should be considered in any child with intellectual disability and absent or severely delayed speech, not only in those with isolated apraxia – the gene is frequently overlooked relative to FOXP2 despite equally strong evidence for its involvement in human language circuits[@deriziotis2017].

FOXP1’s expression in corticobasal ganglia circuits that support procedural motor learning makes it a strong candidate for speech-motor disruption[@deriziotis2017]. The same circuits impaired in FOXP1 syndrome are those damaged in Huntington’s disease, where FOXP1 expression is reduced in the striatum.

Relationship to FOXP2

FOXP1 and FOXP2 are paralogs that co-regulate striatal circuits crucial for speech-motor learning. Both genes bind the same DNA consensus sequence (TAAACA) via their forkhead domains and are co-expressed in Layer 5/6 cortical neurons, Purkinje cells, and striatal medium spiny neurons[@fong2018]. They regulate overlapping sets of target genes including CNTNAP2, NRXN1, and SEMA3E, and can form heterodimers via their leucine zipper domains, enabling coordinated transcriptional regulation[@ahmed2024].

Despite molecular overlap, FOXP1 syndrome (intellectual disability + speech apraxia + autism features) and FOXP2-associated developmental verbal dyspraxia (isolated speech apraxia, largely normal IQ) are clinically distinct – suggesting non-redundant roles in speech circuit development[@lozano2021][@deriziotis2017]. FOXP1’s broader phenotype may reflect its more global impact on brain development compared to FOXP2’s relatively focused role in speech-motor circuits[@hamdan2010].

A key buffering mechanism exists in the striatum: FOXP1 and FOXP2 compensate for each other; loss of one leads to compensatory upregulation of the other, helping explain why single-mutation phenotypes vary widely[@ahmed2024].

Gene Structure and Molecular Function

The FOXP1 gene is located on chromosome 3p13, spanning approximately 400 kb with 23 exons, and encodes a 583 amino acid protein[@fong2018]. The protein contains several functional domains: a forkhead domain serving as a winged-helix DNA-binding domain that recognizes the TAAACA motif, a leucine zipper that enables homo- and heterodimerisation with FOXP2 and FOXP4, a zinc finger functioning as a protein-protein interaction motif, and a glutamine-rich region that serves as a transcriptional activation domain. FOXP1 primarily acts as a transcriptional repressor, though it can activate transcription depending on binding partners and cellular contextPMID:30831269.

Brain Expression and Circuit Role

FOXP1 is highly expressed in several key brain regions that collectively support motor learning, speech production, and cognitive function[@fong2018][@froehlich2017]. In the striatum (caudate/putamen), FOXP1 is expressed in medium spiny neurons where it plays a role in corticostriatal motor learning. Cortical expression in Layer 3/5/6 neurons supports motor planning and association functions, while motor neuron expression in the spinal cord is required for motor neuron subtype specification and limb innervationPMID:36564038. The gene is also expressed in the hippocampus, where it contributes to memory circuit development, and in Purkinje cells where it supports cerebellar circuit formation.

The striatal expression of FOXP1 is particularly important: FOXP1 and FOXP2 co-regulate corticostriatal output that supports the procedural learning of motor sequences, including the complex oral-motor sequences required for speech.

Animal Models

Mouse studies have been highly informative for understanding FOXP1 function, revealing both essential roles and specific deficits relevant to human disease[@froehlich2017]. Nervous-system-specific Foxp1 conditional knockout results in perinatal death from respiratory failure, establishing FOXP1’s essential role in brainstem respiratory circuits. Heterozygous knockouts (Foxp1+/–) show vocalisation deficits and altered striatal neuron excitability, directly modeling the speech-circuit disruption seen in human FOXP1 syndrome.

Neurodegeneration

FOXP1 expression is reduced in the striatum in Huntington’s disease, where medium spiny neurons – the primary site of FOXP1 expression – are selectively lostPMID:39902677. FOXP1 and FOXP2 maintain functional compensation in the striatum under healthy conditions; complete loss of this compensation may contribute to neurodegenerative progression[@ahmed2024].

See Also

• FOXP2 Gene – paralog and heterodimerisation partner
• Speech and Language Disorders
• Autism Spectrum Disorder
• Developmental Verbal Dyspraxia
• Corticostriatal Circuit

Pathway Diagram

The following diagram shows the key molecular relationships involving FOXP1 Gene discovered through SciDEX knowledge graph analysis:

graph TD
    AURKA["AURKA"] -.->|"inhibits"| FOXP1["FOXP1"]
    AURKA["AURKA"] -->|"interacts with"| FOXP1["FOXP1"]
    CD38["CD38"] -->|"therapeutic target"| FOXP1["FOXP1"]
    FOXO6["FOXO6"] -->|"associated with"| FOXP1["FOXP1"]
    FOXO3["FOXO3"] -->|"associated with"| FOXP1["FOXP1"]
    FOXP3["FOXP3"] -->|"associated with"| FOXP1["FOXP1"]
    SHH["SHH"] -->|"expressed in"| FOXP1["FOXP1"]
    FOXG1["FOXG1"] -->|"associated with"| FOXP1["FOXP1"]
    RHOT1["RHOT1"] -->|"associated with"| FOXP1["FOXP1"]
    MIRO1["MIRO1"] -->|"associated with"| FOXP1["FOXP1"]
    GABRA2["GABRA2"] -->|"associated with"| FOXP1["FOXP1"]
    FOXA2["FOXA2"] -->|"associated with"| FOXP1["FOXP1"]
    FOXO1["FOXO1"] -->|"associated with"| FOXP1["FOXP1"]
    FOXO4["FOXO4"] -->|"associated with"| FOXP1["FOXP1"]
    HSPA4["HSPA4"] -->|"regulates"| FOXP1["FOXP1"]
    style AURKA fill:#ce93d8,stroke:#333,color:#000
    style FOXP1 fill:#ce93d8,stroke:#333,color:#000
    style CD38 fill:#ce93d8,stroke:#333,color:#000
    style FOXO6 fill:#ce93d8,stroke:#333,color:#000
    style FOXO3 fill:#ce93d8,stroke:#333,color:#000
    style FOXP3 fill:#ce93d8,stroke:#333,color:#000
    style SHH fill:#ce93d8,stroke:#333,color:#000
    style FOXG1 fill:#ce93d8,stroke:#333,color:#000
    style RHOT1 fill:#ce93d8,stroke:#333,color:#000
    style MIRO1 fill:#ce93d8,stroke:#333,color:#000
    style GABRA2 fill:#ce93d8,stroke:#333,color:#000
    style FOXA2 fill:#ce93d8,stroke:#333,color:#000
    style FOXO1 fill:#ce93d8,stroke:#333,color:#000
    style FOXO4 fill:#ce93d8,stroke:#333,color:#000
    style HSPA4 fill:#ce93d8,stroke:#333,color:#000

References

1. Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1. (Nat Aging, 2024, PMID:38594460)
2. Cancer-induced FOXP1 disrupts and reprograms skeletal-muscle circadian transcription in cachexia. (Cell Rep, 2025, PMID:40349340)
3. Identification of novel <i>FOXP1</i> variants in four unrelated patients with intellectual disability and speech impairment. (Frontiers in neurology, 2026, PMID:41716553)
4. Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway. (Biochim Biophys Acta Gene Regul Mech, 2019, PMID:30831269)
5. Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis. (J Cachexia Sarcopenia Muscle, 2023, PMID:36564038)
6. FOXP1 is a Transcription Factor for the Alzheimer’s Disease Risk Gene SORL1. (J Neurochem, 2025, PMID:39902677)